Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-7168

Statin Therapy for the Prevention & Tx CV Dx CMS347 [clarify active diagnosis DM at any time during measurement period]

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Stacey Arens-Wilson
    • 573-882-2908
    • MUHC
    • Hide
      Thank you for your question regarding 347v7, Statin Therapy for the Prevention and Treatment of Cardiovascular Disease.

      The measure logic references the Diabetes value set (OID 2.16.840.1.113883.3.464.1003.103.12.1001), to establish an ‘Initial Population’ for CMS347v7. If a code within the value set is found within the patients’ medical record, they would meet the ‘risk category’ for ‘Population 3’. In regard to timing, the measure logic requires the documentation of a new or existing diagnosis of Type 1 or Type 2 diabetes; AND that the patient is between 40 and 75 years of age during the measurement period, AND they did not meet the ‘Denominator Exclusion’ or ‘Denominator Exception’ criteria. If these exclusion criteria are not met, the patient would be included in the ‘Population 3’ initial population.

      Specific to your example, if a patient has an active diagnosis of E11.9 (Type 2 diabetes mellitus without complications), AND was between 40 and 75 years of age, during the measurement period, the patient would qualify for the ‘Population 3’ ‘risk category’ for the ‘Initial Population’ for the 2024 calendar year reporting.

      We hope this helps.
      Show
      Thank you for your question regarding 347v7, Statin Therapy for the Prevention and Treatment of Cardiovascular Disease. The measure logic references the Diabetes value set (OID 2.16.840.1.113883.3.464.1003.103.12.1001), to establish an ‘Initial Population’ for CMS347v7. If a code within the value set is found within the patients’ medical record, they would meet the ‘risk category’ for ‘Population 3’. In regard to timing, the measure logic requires the documentation of a new or existing diagnosis of Type 1 or Type 2 diabetes; AND that the patient is between 40 and 75 years of age during the measurement period, AND they did not meet the ‘Denominator Exclusion’ or ‘Denominator Exception’ criteria. If these exclusion criteria are not met, the patient would be included in the ‘Population 3’ initial population. Specific to your example, if a patient has an active diagnosis of E11.9 (Type 2 diabetes mellitus without complications), AND was between 40 and 75 years of age, during the measurement period, the patient would qualify for the ‘Population 3’ ‘risk category’ for the ‘Initial Population’ for the 2024 calendar year reporting. We hope this helps.
    • CMS0347v8
    • CMS0347v7
    • this may inflate Population 3 denominator if interpreted incorrectly.

      Regarding: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

      Collection Type – 2024 eCQMs

      https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS347v7.html

      Population 3: Patients aged 40 to 75 years of age at the beginning of the measurement period with an active diagnosis of Type 1 or Type 2 diabetes at any time during the measurement period.

       

      [1]           Please clarify definition of “active diagnosis of Type 1 or Type 2 diabetes at any time during the measurement period.” 

      [2]           Will a patient with a diagnosis prior to the measurement period [for example diagnosis of E11.9 associated to an encounter or submitted on claim DOS 6/25/2019] qualify for Population 3 denominator for 2024 calendar year reporting? 

            edave Mathematica EC eCQM Team
            Arenss_0209 Stacey R Arens-Wilson (Inactive)
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: